Literature DB >> 21843636

Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.

Michael G Borland1, Combiz Khozoie, Prajakta P Albrecht, Bokai Zhu, Christina Lee, Tejas S Lahoti, Frank J Gonzalez, Jeffrey M Peters.   

Abstract

Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) function and receptor cross-talk with other nuclear receptors, including PPARγ and retinoic acid receptors (RARs), was examined using stable human HaCaT keratinocyte cell lines over-expressing PPARβ/δ or PPARγ. Enhanced ligand-induced expression of two known PPAR target genes, adipocyte differentiation-related protein (ADRP) and angiopoietin-like protein 4 (ANGPTL4), was found in HaCaT keratinocytes over-expressing PPARβ/δ or PPARγ. Over-expression of PPARβ/δ did not modulate the effect of a PPARγ agonist on up-regulation of ADRP or ANGPTL4 mRNA in HaCaT keratinocytes. All-trans retinoic acid (atRA) increased expression of a known RAR target gene, yet despite a high ratio of fatty acid binding protein 5 (FABP5) to cellular retinoic acid binding protein II, did not increase expression of ANGPTL4 or 3-phosphoinositide-dependent-protein kinase 1 (PDPK1), even in HaCaT keratinocytes expressing markedly higher levels of PPARβ/δ. While PPARβ/δ-dependent attenuation of staurosporine- or UVB-induced poly (ADP-ribose) polymerase (PARP) cleavage was not observed, PPARβ/δ- and PPARγ-dependent repression of UVB-induced expression and secretion of inflammatory cytokines was found in HaCaT keratinocytes over-expressing PPARβ/δ or PPARγ. These studies suggest that FABP5 does not transport atRA or GW0742 to PPARβ/δ and promote anti-apoptotic activity by increasing expression of PDPK1, or that PPARβ/δ interferes with PPARγ transcriptional activity. However, these studies demonstrate that stable over-expression of PPARβ/δ or PPARγ significantly increases the efficacy of ligand activation and represses UVB-induced expression of tumor necrosis factor α (TNFα), interleukin 6 (IL6), or IL8 in HaCaT keratinocytes, thereby establishing an excellent model to study the functional role of these receptors in human keratinocytes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843636      PMCID: PMC3184348          DOI: 10.1016/j.cellsig.2011.07.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  35 in total

1.  Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

Authors:  Nicolas Di-Poï; Nguan Soon Tan; Liliane Michalik; Walter Wahli; Béatrice Desvergne
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

2.  Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

Authors:  Yaacov Barak; Debbie Liao; Weimin He; Estelita S Ong; Michael C Nelson; Jerrold M Olefsky; Richard Boland; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.

Authors:  W R Oliver; J L Shenk; M R Snaith; C S Russell; K D Plunket; N L Bodkin; M C Lewis; D A Winegar; M L Sznaidman; M H Lambert; H E Xu; D D Sternbach; S A Kliewer; B C Hansen; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

4.  The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

Authors:  Yanhong Shi; Michelle Hon; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.

Authors:  M Westergaard; J Henningsen; M L Svendsen; C Johansen; U B Jensen; H D Schrøder; I Kratchmarova; R K Berge; L Iversen; L Bolund; K Kragballe; K Kristiansen
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

Review 6.  Recent advances in peroxisome proliferator-activated receptor science.

Authors:  Barry G Shearer; William J Hoekstra
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

7.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.

Authors:  Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

8.  PPARdelta is a very low-density lipoprotein sensor in macrophages.

Authors:  Ajay Chawla; Chih-Hao Lee; Yaacov Barak; Weimin He; John Rosenfeld; Debbie Liao; Jungyeob Han; Heonjoong Kang; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

9.  Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.

Authors:  Dae J Kim; Taro E Akiyama; Fred S Harman; Amanda M Burns; Weiwei Shan; Jerrold M Ward; Mary J Kennett; Frank J Gonzalez; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2004-03-19       Impact factor: 5.157

10.  Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.

Authors:  Marcos L Sznaidman; Curt D Haffner; Patrick R Maloney; Adam Fivush; Esther Chao; Donna Goreham; Michael L Sierra; Christelle LeGrumelec; H Eric Xu; Valerie G Montana; Millard H Lambert; Timothy M Willson; William R Oliver; Daniel D Sternbach
Journal:  Bioorg Med Chem Lett       Date:  2003-05-05       Impact factor: 2.940

View more
  23 in total

Review 1.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

2.  Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.

Authors:  Michael G Borland; Prasad Krishnan; Christina Lee; Prajakta P Albrecht; Weiwei Shan; Moses T Bility; Craig B Marcus; Jyh M Lin; Shantu Amin; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2014-03-17       Impact factor: 4.944

3.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

4.  PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.

Authors:  Maryam Goudarzi; Takayuki Koga; Combiz Khozoie; Tytus D Mak; Boo-Hyon Kang; Albert J Fornace; Jeffrey M Peters
Journal:  Toxicology       Date:  2013-07-10       Impact factor: 4.221

5.  Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunction.

Authors:  Ravi P Sahu; Sonia C DaSilva; Badri Rashid; Kellie Clay Martel; Danielle Jernigan; Shama R Mehta; Deena R Mohamed; Samin Rezania; Joshua R Bradish; Andrew B Armstrong; Simon Warren; Raymond L Konger
Journal:  Int J Cancer       Date:  2012-04-18       Impact factor: 7.396

Review 6.  Functions of Intracellular Retinoid Binding-Proteins.

Authors:  Joseph L Napoli
Journal:  Subcell Biochem       Date:  2016

7.  Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.

Authors:  Michael G Borland; Ellen M Kehres; Christina Lee; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2018-05-03       Impact factor: 4.221

Review 8.  Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.

Authors:  William S Blaner
Journal:  Pharmacol Ther       Date:  2019-01-29       Impact factor: 12.310

9.  Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Authors:  Pei-Li Yao; Jose L Morales; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cancer Ther       Date:  2014-01-24       Impact factor: 6.261

10.  The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.

Authors:  Bokai Zhu; Christina H Ferry; Lauren K Markell; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2014-06-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.